Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127233251 | 12723325 | 1 | I | 20160824 | 20160908 | 20160908 | EXP | US-APOTEX-2016AP010933 | APOTEX | KAUFMAN KR, NEWMAN NB, DAWOOD A.. CAPGRAS DELUSION WITH VIOLENT BEHAVIOR IN ALZHEIMER DEMENTIA: CASE ANALYSIS WITH LITERATURE REVIEW. ANN-CLIN-PSYCHIATRY. 2014;26(2):E9-E13 | 75.00 | YR | M | Y | 0.00000 | 20160908 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127233251 | 12723325 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 15MG NIGHTLY AT BEDTIME | Y | 90798 | 15 | MG | TABLET | QD | |||||
127233251 | 12723325 | 2 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | 100 MG, BID | Y | 0 | 100 | MG | TABLET | BID | |||||
127233251 | 12723325 | 3 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | 20 MG, Q.AM | Y | 0 | 20 | MG | QD | ||||||
127233251 | 12723325 | 4 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | 30 MG, Q.H.S. NIGHTLY AT BEDTIME | Y | 0 | 30 | MG | QD | ||||||
127233251 | 12723325 | 5 | SS | CHLORDIAZEPOXIDE. | CHLORDIAZEPOXIDE | 1 | Unknown | 50 MG, Q.AM | Y | 0 | 50 | MG | QD | ||||||
127233251 | 12723325 | 6 | SS | CHLORDIAZEPOXIDE. | CHLORDIAZEPOXIDE | 1 | Unknown | 75 MG, Q.H.S.NIGHTLY AT BEDTIME | Y | 0 | 75 | MG | QD | ||||||
127233251 | 12723325 | 7 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | 100 MG, Q.H.S.NIGHTLY AT BEDTIME | 0 | 100 | MG | QD | |||||||
127233251 | 12723325 | 8 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 50 MG, Q.AMIN THE MORNING | 0 | 50 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127233251 | 12723325 | 1 | Dementia Alzheimer's type |
127233251 | 12723325 | 2 | Dementia Alzheimer's type |
127233251 | 12723325 | 3 | Dementia Alzheimer's type |
127233251 | 12723325 | 5 | Dementia Alzheimer's type |
127233251 | 12723325 | 7 | Dementia Alzheimer's type |
127233251 | 12723325 | 8 | Dementia Alzheimer's type |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127233251 | 12723325 | OT |
127233251 | 12723325 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127233251 | 12723325 | Aggression | |
127233251 | 12723325 | Condition aggravated | |
127233251 | 12723325 | Delusion of replacement | |
127233251 | 12723325 | Dementia | |
127233251 | 12723325 | Drug administered to patient of inappropriate age | |
127233251 | 12723325 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |